Hubungan Pengendalian Diabetes Melitus Type 2 Dengan Kejadian Retinopati Diabetes Di Rsud Dr Chasan Boesoirie Ternate

Authors

  • Eko Sudarmo Dahad Prihanto Fakultas Kedokteran, Universitas Khairun, Ternate, Indonesia
  • Yetrina Yetrina Fakultas Kedokteran, Universitas Khairun, Ternate, Indonesia
  • Muhammad Sultan Firman Syah Fakultas Kedokteran, Universitas Khairun, Ternate, Indonesia
  • Andri W Johan Imbar Fakultas Kedokteran, Universitas Khairun, Ternate, Indonesia

DOI:

https://doi.org/10.46799/jhs.v3i12.698

Keywords:

Diabetes Melitus, Pengendalian Glikemi, HbA1, Retinopati Diabetes

Abstract

Background: Controlling type 2 diabetes mellitus (DMT2) is very important in reducing the possibility of complications. The incidence of complications of DMT2 includes macrovascular and microvascular. An important microvascular complication is diabetic retinopathy, which is strongly influenced by the duration of diabetes, hyperglycemia and hypertension. Many studies with mixed results regarding the relationship of controlled diabetes with the incidence of diabetic retinopathy. Purpose: This study aims to determine the relationship between T2DM control and the incidence of diabetic retinopathy at Dr Chasan Boesoirie Hospital Ternate. Methods: This study used an analytic observation design with a cross sectional approach. DMT2 patients who visit the internal medicine polyclinic are examined for HbA1c and examined by an ophthalmologist to diagnose the presence or absence of diabetic retinopathy. Samples were taken by purposive sampling. Correlation test analysis was carried out with the Chi Square test. Results: In DMT2 who visited the Internal Medicine Polyclinic at Dr. Chasan Boesoirie found. Conclusion: There is a non-significant relationship with p=0.179 between controlled T2DM and the incidence of diabetic retinopathy. Early detection of diabetic retinopathy is required by funduscopic examination with regard to the status of T2DM control

References

Ansari, P., Tabasumma, N., Snigdha, N. N., Siam, N. H., Panduru, R. V., Azam, S., Hannan, J. M. A., & Abdel-Wahab, Y. H. A. (2022). Diabetic Retinopathy: An Overview On Mechanisms, Pathophysiology And Pharmacotherapy. Diabetology, 3(1), 159–175.

Association, A. D. (2020). 11. Microvascular Complications And Foot Care: Standards Of Medical Care In Diabetes− 2020. Diabetes Care, 43(Supplement_1), S135–S151.

Chandra, P., Rahayu, S. R. B., & Melani, E. (2021). Hubungan Antara Hba1c Dengan Tingkat Keparahan Retinopati Diabetika Pada Pasien Dm Di Klinik Mata Nusantara Jakarta. Jurnal Sains Kesehatan, 28(2), 44–51.

Fadli, N. (2016). Hubungan Kadar Hba1c Terhadap Retinopati Diabetik Pada Pasien Dm Tipe 2 Di Rsud Dr. Saiful Anwar Malang. University Of Muhammadiyah Malang.

Indonesia, P. E. (2015). Pengelolaan Dan Pencegahan Diabetes Melitus Tipe 2 Di Indonesia. Pb. Perkeni.

Kautzky-Willer, A., Harreiter, J., & Pacini, G. (2016). Sex And Gender Differences In Risk, Pathophysiology And Complications Of Type 2 Diabetes Mellitus. Endocrine Reviews, 37(3), 278–316.

Kilpatrick, E. S., Rigby, A. S., Atkin, S. L., & Barth, J. H. (2013). Glycemic Control In The 12 Months Following A Change To Si Hemoglobin A1c Reporting Units. Clinical Chemistry, 59(10), 1457–1460.

Mauvais-Jarvis, F. (2018). Gender Differences In Glucose Homeostasis And Diabetes. Physiology & Behavior, 187, 20–23.

Milita, F., Handayani, S., & Setiaji, B. (2021). Kejadian Diabetes Mellitus Tipe Ii Pada Lanjut Usia Di Indonesia (Analisis Riskesdas 2018). Jurnal Kedokteran Dan Kesehatan, 17(1), 9–20.

Putri, L. K., Karimi, J., & Nugraha, D. P. (2017). Profil Pengendalian Diabetes Melitus Tipe 2 Di Poliklinik Penyakit Dalam Rsud Arifin Achmad Pekanbaru. Jurnal Ilmu Kedokteran (Journal Of Medical Science), 8(1), 18–24.

Rübsam, A., Parikh, S., & Fort, P. E. (2018). Role Of Inflammation In Diabetic Retinopathy. International Journal Of Molecular Sciences, 19(4), 942.

Sherwani, S. I., Khan, H. A., Ekhzaimy, A., Masood, A., & Sakharkar, M. K. (2016). Significance Of Hba1c Test In Diagnosis And Prognosis Of Diabetic Patients. Biomarker Insights, 11, Bmi-S38440.

Shiferaw, W. S., Akalu, T. Y., Desta, M., Kassie, A. M., Petrucka, P. M., Assefa, H. K., & Aynalem, Y. A. (2020). Glycated Hemoglobin A1c Level And The Risk Of Diabetic Retinopathy In Africa: A Systematic Review And Meta-Analysis. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 14(6), 1941–1949.

Simó-Servat, O., Hernández, C., & Simó, R. (2019). Diabetic Retinopathy In The Context Of Patients With Diabetes. Ophthalmic Research, 62(4), 211–217.

Smokovski, I. (2021). Managing Diabetes In Low Income Countries. Springer.

Song, P., Yu, J., Chan, K. Y., Theodoratou, E., & Rudan, I. (2018). Prevalence, Risk Factors And Burden Of Diabetic Retinopathy In China: A Systematic Review And Meta-Analysis. Journal Of Global Health, 8(1).

Stewart, J. M., Coassin, M., & Schwartz, D. M. (2009). Diabetic Complications. Diabetic Retinopathy [Homepage On The Internet].

Wang, M., & Hng, T.-M. (2021). Hba1c: More Than Just A Number. Australian Journal Of General Practice, 50(9), 628–632.

Wong, T. Y., Cheung, C. M. G., Larsen, M., Sharma, S., & Simó, R. (2016). Erratum: Diabetic Retinopathy. Nature Reviews Disease Primers, 2(1), 1.

Downloads

Published

2022-12-13